Riyadh, KSA- September 2024- Lifera Omics appoints Prof. Fowzan Sami Alkuraya as Chief Medical and Genomics Officer and adds him to the Board of Lifera Omics. Prof. Alkuraya’s deep experience in human genomics built over 17 years will contribute significantly in enabling Lifera Omics’ objectives.
Prof. Alkuraya, a former Chairman of Translational Genomics at King Faisal Specialist Hospital and Research Centre in Riyadh and current Professor of Human Genetics at Alfaisal University, has significantly contributed to the field of genomics, through over 590 scientific publications in prestigious international journals and as a frequent speaker at international scientific conferences on genomic medicine and precision health.
Also Read: Yale School of Medicine Appoints Mona Sharifi as Section Chief of General Pediatrics
Prof. Alkuraya garnered numerous prestigious awards, including the William King Wilson Prize in Genetics from Harvard Medical School, the King Salman Award for Disability Research, and the Curt Stern Award from the American Society of Human Genetics. the first non-US based recipient of this honor. He also won Kwiat Prize for Basic Medical Science Subject Area and Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.
“We are delighted to welcome such a trusted and respected leader to the Lifera Omics Executive Leadership team,” said Dr. Ibrahim Juffali, Chairman of Lifera. “Dr. Fowzan’s deep clinical and scientific expertise will be instrumental in helping Lifera achieve its mission to improve Saudi Arabia’s biopharma resilience and to enable the National Biotech Strategy.”
